Legal Opinion
Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc.
Court of Appeals for the Federal Circuit
Decided June 20, 2019No. 2017-2498, 2017-2499, 2017-2545, 2017-2546PublishedCited by 15 opinions
1Opinion of the Court
Prost, Chief Judge.
Enzo Life Sciences, Inc. ("Enzo") appeals the decision of the U.S. District Court for the District of Delaware granting summary judgment against Enzo and holding that the asserted claims are invalid for lack of enablement. We affirm as to non-enablement and do not reach the other issues presented on appeal.
I
Deoxyribonucleic acid ("DNA") and ribonucleic acid ("RNA") are nucleic acids. They are made of a series of building blocks, called nucleotides, linked together in a chain. A single nucleotide is made up of a sugar, a phosphate, and a nitrogenous base. DNA nucleotides…
2Cases cited12 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Genentech, Inc. v. Novo Nordisk, A/s, Novo Nordisk of North America, Inc. And Novo Nordisk Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 1997
- Atlas Powder Company v. E.I. Du Pont De Nemours & Company and Alamo Explosives Company, Inc.Court of Appeals for the Federal Circuit · 1984
- In Re Jack R. Wands, Vincent R. Zurawski, Jr., and Hubert J.P. SchoemakerCourt of Appeals for the Federal Circuit · 1988
- Ruehl v. Viacom, Inc.Court of Appeals for the Third Circuit · 2007
7 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Idenix Pharmaceuticals LLC v. Gilead Sciences Inc.Court of Appeals for the Federal Circuit · 2019
- McRo, Inc. v. Bandai Namco Games AmericaCourt of Appeals for the Federal Circuit · 2020
- Amgen Inc. v. SanofiCourt of Appeals for the Federal Circuit · 2021
- Amgen Inc. v. SanofiDistrict Court, D. Delaware · 2019
- AstraZeneca AB v. Mylan Pharmaceuticals Inc.District Court, N.D. West Virginia · 2022
10 more not listed; retrieve them via the Exa API.